Our methods can facilitate TFE3-RCC diagnosis based on routinely collected H&E-stained histopathology slides, thereby contributing to accurate sample curation and treatment development of this rare and aggressive cancer subtype. Here, TFE3 is linked to renal cell carcinoma.